about
Human papillomavirus and cervical cancer: biomarkers for improved prevention effortsHuman Papillomavirus (HPV) Prevalence in Nasal and Antrochoanal Polyps and Association with Clinical Data.Apoptosis induction in Jurkat cells and sCD95 levels in women's sera are related with the risk of developing cervical cancerCell-cycle and suppressor proteins expression in uterine cervix in HIV/HPV co-infection: comparative study by tissue micro-array (TMA).Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.Prognostic significance of overexpressed p16INK4a in patients with cervical cancer: a meta-analysisHPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors.p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysisAcademic College of Emergency Experts in India's INDO-US Joint Working Group and OPUS12 Foundation Consensus Statement on Creating A Coordinated, Multi-Disciplinary, Patient-Centered, Global Point-of-Care Biomarker Discovery NetworkE4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease[Molecular diagnosis of HPV infections].Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.Human papillomavirus testing in the prevention of cervical cancerQuantitative survey of multiple CpGs from 5 genes identifies CpG methylation panel discriminating between high- and low-grade cervical intraepithelial neoplasiaTranscriptionally active regions are the preferred targets for chromosomal HPV integration in cervical carcinogenesis.Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling.Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs.Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.Laboratory and clinical aspects of human papillomavirus testingOptimizing technology for cervical cancer screening in high-resource settings.A review of methods for detect human Papillomavirus infectionZinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasiaNaturopathic management of females with cervical atypia: a delphi process to explore current practice.Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.Evaluation of Ki67, p16 and CK17 Markers in Differentiating Cervical Intraepithelial Neoplasia and Benign Lesions.Human papillomavirus DNA methylation as a potential biomarker for cervical cancer.Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.Cervical cancer prevention--cervical screening: science in evolution.Cervical cancer screening: from molecular basis to diagnostic practice, going through new technologies.Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.Early detection of cervical carcinomas: finding an overall approachEvaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.Human papillomavirus infection and the primary and secondary prevention of cervical cancer.Human papillomavirus and molecular considerations for cancer risk.p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.
P2860
Q27023127-50A359AC-1CEF-4ABF-947C-539D4C6705A1Q31012345-6DEAF3E3-385D-429E-89D1-38A86A05F3C9Q33327764-3FC669E0-A12E-40D8-B7FC-1B568EBAB7F2Q33374407-43510E33-231C-4E33-935F-2397ED35773BQ33978458-7618F8C7-D09E-4FF7-A445-A514544951D0Q34133777-59294C36-7342-47E4-B1C1-3521E3EC0775Q34138292-61B42257-D34C-459F-907D-A807129C973FQ34254020-E88045C6-2991-4187-9CC8-D80CFBA66B77Q34334875-A1BF7F75-9365-4FC4-AB18-3C0F5ACA5138Q34344782-6063131D-B527-4207-A4C7-E88F441E9A15Q34357303-58EFF865-0023-4A66-B31E-895D2FC7D27BQ34506439-EE90629E-F8E9-401C-874A-DA51ED6D4614Q34543310-FD3FB889-54B2-4AA8-94CD-98822525CF9FQ34543338-A6C2ED32-995E-4530-BEAE-7C83908F4450Q34616083-E2600A5E-4DC7-4446-964E-7BEE053F39F5Q35101902-EC6F74DB-4ACF-4091-BAB0-39DCCD54C3DEQ35203515-E7A7CB14-7E64-4E08-AA2E-643EBB7C4933Q35796047-8F7FEDDE-82CA-463B-BCC0-4A4D50BCB770Q35864909-158D9BD7-18A1-45A4-B15D-E2759E4B4074Q36159360-5558E93A-F1A9-493D-B4C5-51DB1E3E8D24Q36311573-A13AE88A-A9D6-4963-BAD1-AC2585EA25C4Q36319941-CDFAD14C-C99D-4209-89A9-0AAD321CA6CDQ36427451-8241A76F-F0DA-450F-A4CE-BC7DDAE8E37DQ36437222-06DE0FC8-BDDC-432C-85DF-C049B189D8C1Q36590626-6D8789AE-F57B-4D80-A8F5-94BE5AB480E7Q36606686-7B211AAD-FC43-46C1-AA74-D8E6A980BEE8Q36813062-4B1D5E28-79A6-4DDA-B58F-F57A971DF073Q36876059-C1B8A798-6081-4F09-9A48-98199EE6BF23Q37013482-9CFA8512-9354-4FEA-9723-3EDDB29EFCEBQ37025594-4F24E00D-4A04-46D2-BAD0-C2840598C561Q37160475-033981ED-02F0-4343-BAB6-37ABAE48061AQ37170521-7039ED8A-CEBE-40D1-A54E-CC8FCC0A8BA6Q37188108-1F6C58DD-0AF5-4009-9E3D-DFA15F6C26EAQ37225246-298246E4-9F70-4019-A964-E12AF04B529BQ37256248-1152F7A5-3E05-4972-84D5-60C8741FE3EBQ37271280-7FF67248-EC7C-4172-A2FF-CDDB9F9A9BF1Q37271947-21CD3CA8-86A2-4FA6-AC54-0ACB81A14816Q37315925-B97ABABD-1F7A-4416-93AD-96BFF850A2EDQ37406427-72FD8664-B3F2-41A9-A83F-DBCAF39855A3Q37484683-6FDF6014-2F47-45D7-94B7-D1E79EC32BCB
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Biomarkers in cervical cancer screening
@ast
Biomarkers in cervical cancer screening
@en
Biomarkers in cervical cancer screening
@en-gb
Biomarkers in cervical cancer screening
@nl
type
label
Biomarkers in cervical cancer screening
@ast
Biomarkers in cervical cancer screening
@en
Biomarkers in cervical cancer screening
@en-gb
Biomarkers in cervical cancer screening
@nl
altLabel
Biomarkers in Cervical Cancer Screening
@en
prefLabel
Biomarkers in cervical cancer screening
@ast
Biomarkers in cervical cancer screening
@en
Biomarkers in cervical cancer screening
@en-gb
Biomarkers in cervical cancer screening
@nl
P921
P3181
P356
P1433
P1476
Biomarkers in cervical cancer screening
@en
P2093
Magnus von Knebel Doeberitz
P304
P3181
P356
10.1155/2007/678793
P407
P577
2007-01-01T00:00:00Z